1
|
Pokhrel D, Sood S, McClinton C, Saleh H, Badkul R, Jiang H, Stepp T, Camarata P, Wang F. Linac-based stereotactic radiosurgery (SRS) in the treatment of refractory trigeminal neuralgia: Detailed description of SRS procedure and reported clinical outcomes. J Appl Clin Med Phys 2017; 18:136-143. [PMID: 28300370 PMCID: PMC5689965 DOI: 10.1002/acm2.12057] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2016] [Revised: 11/28/2016] [Accepted: 01/11/2017] [Indexed: 11/23/2022] Open
Abstract
Purpose/Objectives To present our linac‐based SRS procedural technique for medically and/or surgically refractory trigeminal neuralgia (TN) treatment and simultaneously report our clinical outcomes. Materials and Methods Twenty‐seven refractory TN patients who were treated with a single fraction of 80 Gy to TN. Treatment delivery was performed with a 4 mm cone size using 7‐arc arrangement with differential‐weighting for Novalis‐TX with six MV‐SRS (1000 MU/min) beam and minimized dose to the brainstem. Before each treatment, Winston–Lutz quality assurance (QA) with submillimeter accuracy was performed. Clinical treatment response was evaluated using Barrow Neurological Institute (BNI) pain intensity score, rated from I to V. Results Out of 27 patients, 22 (81%) and 5 (19%) suffered from typical and atypical TN, respectively, and had median follow‐up interval of 12.5 months (ranged: 1–53 months). For 80 Gy prescriptions, delivered total average MU was 19440 ± 611. Average beam‐on‐time was 19.4 ± 0.6 min. Maximum dose and dose to 0.5 cc of brainstem were 13.4 ± 2.1 Gy (ranged: 8.4–15.9 Gy) and 3.6 ± 0.4 Gy (ranged: 3.0–4.9 Gy), respectively. With a median follow‐up of 12.5 months (ranged: 1–45 months) in typical TN patients, the proportion of patients achieving overall pain relief was 82%, of which half achieved a complete pain relief with BNI score of I‐II and half demonstrated partial pain reduction with BNI score of IIIA‐IIIB. Four typical TN patients (18%) had no response to radiosurgery treatment. Of the patients who responded to treatment, actuarial pain recurrence free survival rates were approximately 100%, 75%, and 50% at 12 months, 15 months, and 24 months, respectively. Five atypical TN patients were included, who did not respond to treatment (BNI score: IV–V). However, no radiation‐induced cranial‐toxicity was observed in all patients treated. Conclusion Linac‐based SRS for medically and/or surgically refractory TN is a fast, effective, and safe treatment option for patients with typical TN who had excellent response rates. Patients, who achieve response to treatment, often have durable response rates with moderate actuarial pain recurrence free survival. Longer follow‐up interval is anticipated to confirm our clinical observations.
Collapse
Affiliation(s)
- Damodar Pokhrel
- Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, USA
| | - Sumit Sood
- Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, USA
| | - Christopher McClinton
- Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, USA
| | - Habeeb Saleh
- Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, USA
| | - Rajeev Badkul
- Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, USA
| | - Hongyu Jiang
- Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, USA
| | - Timothy Stepp
- Department of Neurosurgery, The University of Kansas Cancer Center, Kansas City, KS, USA
| | - Paul Camarata
- Department of Neurosurgery, The University of Kansas Cancer Center, Kansas City, KS, USA
| | - Fen Wang
- Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, USA
| |
Collapse
|
2
|
Molinier J, Kerr C, Simeon S, Ailleres N, Charissoux M, Azria D, Fenoglietto P. Comparison of volumetric-modulated arc therapy and dynamic conformal arc treatment planning for cranial stereotactic radiosurgery. J Appl Clin Med Phys 2016; 17:92-101. [PMID: 26894335 PMCID: PMC5690199 DOI: 10.1120/jacmp.v17i1.5677] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2015] [Revised: 10/14/2015] [Accepted: 10/07/2015] [Indexed: 11/23/2022] Open
Abstract
The aim was to analyze arc therapy techniques according to the number and position of the brain lesions reported by comparing dynamic noncoplanar conformal arcs (DCA), two coplanar full arcs (RAC) with volumetric-modulated arc therapy (VMAT), multiple noncoplanar partial arcs with VMAT (RANC), and two full arcs with VMAT and 10° table rotation (RAT). Patients with a single lesion (n= 10), multiple lesions (n = 10) or a single lesion close to organs at risk (n = 5) and previously treated with DCA were selected. For each patient, the DCA treatment was replanned with all VMAT techniques. All DCA plans were compared with VMAT plans and evaluated in regard to the different quality indices and dosimetric parameters. For single lesion, homogeneity index (HI) better results were found for the RANC technique (0.17 ± 0.05) compared with DCA procedure (0.27± 0.05). Concerning conformity index (CI), the RAT technique gave higher and better values (0.85 ± 0.04) compared with those obtained with the DCA technique (0.77 ± 0.05). DCA improved healthy brain protection (8.35 ± 5.61 cc vs. 10.52 ± 6.40 cc for RANC) and reduced monitor unit numbers (3046 ± 374 MU vs. 4651 ± 736 for RANC), even if global room occupation was higher. For multiple lesions, VMAT techniques provided better HI (0.16) than DCA (0.24 ± 0.07). The CI was improved with RAT (0.8 ± 0.08 for RAT vs. 0.71 ± 0.08 for DCA). The V10Gy healthy brain was better protected with DCA (9.27 ± 4.57 cc). Regarding the MU numbers: RANC < RAT< RAC < DCA. For a single lesion close to OAR, RAT achieved high degrees of homogeneity (0.27 ± 0.03 vs. 0.53 ± 0.2 for DCA) and conformity (0.72± 0.06vs. 0.56 ± 0.13 for DCA) while sparing organs at risk (Dmax = 12.36 ± 1.05Gyvs. 14.12 ± 0.59 Gy for DCA, and Dmean = 3.96 ± 3.57Gyvs. 4.72 ± 3.28Gy for DCA). On the other hand, MU numbers were lower with DCA (2254 ± 190 MUvs. 3438 ± 457 MU for RANC) even if overall time was inferior with RAC. For a single lesion, DCA provide better plan considering low doses to healthy brain even if quality indexes are better for the others techniques. For multiple lesions, RANC seems to be the best compromise, due to the ability to deliver a good conformity and homogeneity plan while sparing healthy brain tissue. For a single lesion close to organs at risk, RAT is the most appropriate technique.
Collapse
|
3
|
Burnet N, Jena R, Burton K, Tudor G, Scaife J, Harris F, Jefferies S. Clinical and Practical Considerations for the Use of Intensity-modulated Radiotherapy and Image Guidance in Neuro-oncology. Clin Oncol (R Coll Radiol) 2014; 26:395-406. [DOI: 10.1016/j.clon.2014.04.024] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2014] [Accepted: 04/04/2014] [Indexed: 12/26/2022]
|
4
|
Lesiuk MJ, Spencer DP, Chan AK, Voroney JP, Lau H. Image-Guided Treatment of Fractionated Stereotactic Radiotherapy Patients: A Quantitative Analysis of Pre- and Post-Treatment Orthogonal kV Images of Patients Immobilized with Thermoplastic Masks. J Med Imaging Radiat Sci 2012; 43:239-244. [DOI: 10.1016/j.jmir.2012.07.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2011] [Revised: 06/19/2012] [Accepted: 07/04/2012] [Indexed: 10/27/2022]
|
5
|
Winey B, Daartz J, Dankers F, Bussière M. Immobilization precision of a modified GTC frame. J Appl Clin Med Phys 2012; 13:3690. [PMID: 22584167 PMCID: PMC5716563 DOI: 10.1120/jacmp.v13i3.3690] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2011] [Revised: 12/19/2011] [Accepted: 12/22/2011] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to evaluate and quantify the interfraction reproducibility and intrafraction immobilization precision of a modified GTC frame. The error of the patient alignment and imaging systems were measured using a cranial skull phantom, with simulated, predetermined shifts. The kV setup images were acquired with a room‐mounted set of kV sources and panels. Calculated translations and rotations provided by the computer alignment software relying upon three implanted fiducials were compared to the known shifts, and the accuracy of the imaging and positioning systems was calculated. Orthogonal kV setup images for 45 proton SRT patients and 1002 fractions (average 22.3 fractions/patient) were analyzed for interfraction and intrafraction immobilization precision using a modified GTC frame. The modified frame employs a radiotransparent carbon cup and molded pillow to allow for more treatment angles from posterior directions for cranial lesions. Patients and the phantom were aligned with three 1.5 mm stainless steel fiducials implanted into the skull. The accuracy and variance of the patient positioning and imaging systems were measured to be 0.10±0.06 mm, with the maximum uncertainty of rotation being ±0.07°.957 pairs of interfraction image sets and 974 intrafraction image sets were analyzed. 3D translations and rotations were recorded. The 3D vector interfraction setup reproducibility was 0.13 mm ±1.8 mm for translations and the largest uncertainty of ±1.07° for rotations. The intrafraction immobilization efficacy was 0.19 mm ±0.66 mm for translations and the largest uncertainty of ±0.50° for rotations. The modified GTC frame provides reproducible setup and effective intrafraction immobilization, while allowing for the complete range of entrance angles from the posterior direction. PACS number: 87.53.Ly, 87.55.Qr
Collapse
Affiliation(s)
- Brian Winey
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
| | | | | | | |
Collapse
|
6
|
Potluri S, Jefferies S, Jena R, Harris F, Burton K, Prevost A, Burnet N. Residual Postoperative Tumour Volume Predicts Outcome after High-dose Radiotherapy for Chordoma and Chondrosarcoma of the Skull Base and Spine. Clin Oncol (R Coll Radiol) 2011; 23:199-208. [DOI: 10.1016/j.clon.2010.09.011] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2010] [Revised: 09/06/2010] [Accepted: 09/28/2010] [Indexed: 11/27/2022]
|
7
|
Li S, Kleinberg LR, Rigamonti D, Wharam MD, Rashid A, Jackson J, Djajaputra D, He S, Creasey T, DeWeese TL. Clinical results of a pilot study on stereovision-guided stereotactic radiotherapy and intensity modulated radiotherapy. Technol Cancer Res Treat 2011; 9:603-17. [PMID: 21070083 DOI: 10.1177/153303461000900609] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Real-time stereovision-guidance has been introduced for efficient and convenient fractionated stereotactic radiotherapy (FSR) and image-guided intensity-modulated radiation therapy (IMRT). This first pilot study is to clinically evaluate its accuracy and precision as well as impact on treatment doses. Sixty-one FSR patients wearing stereotactic masks (SMs) and nine IMRT patients wearing flexible masks (FMs), were accrued. Daily target reposition was initially based-on biplane-radiographs and then adjusted in six degrees of freedom under real-time stereovision guidance. Mean and standard deviation of the head displacements measured the accuracy and precision. Head positions during beam-on times were measured with real-time stereovisions and used for determination of delivered doses. Accuracy ± ± precision in direction with the largest errors shows improvement from 0.4 ± 2.3 mm to 0.0 ± 1.0 mm in the inferior-to-superior direction for patients wearing SM or from 0.8 ± 4.3 mm to 0.4 ± 1.7 mm in the posterior-to-anterior direction for patients wearing FM. The image-guidance increases target volume coverage by >30% for small lesions. Over half of head position errors could be removed from the stereovision-guidance. Importantly, the technique allows us to check head position during beam-on time and makes it possible for having frameless head refixation without tight masks.
Collapse
Affiliation(s)
- Shidong Li
- Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Das S, Isiah R, Rajesh B, Ravindran BP, Singh RR, Backianathan S, Subhashini J. Accuracy of relocation, evaluation of geometric uncertainties and clinical target volume (CTV) to planning target volume (PTV) margin in fractionated stereotactic radiotherapy for intracranial tumors using relocatable Gill-Thomas-Cosman (GTC) frame. J Appl Clin Med Phys 2010; 12:3260. [PMID: 21587166 PMCID: PMC5718666 DOI: 10.1120/jacmp.v12i2.3260] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2010] [Revised: 10/19/2010] [Accepted: 10/19/2010] [Indexed: 12/25/2022] Open
Abstract
The present study is aimed at determination of accuracy of relocation of Gill-Thomas-Cosman frame during fractionated stereotactic radiotherapy. The study aims to quantitatively determine the magnitudes of error in anteroposterior, mediolateral and craniocaudal directions, and determine the margin between clinical target volume to planning target volume based on systematic and random errors. Daily relocation error was measured using depth helmet and measuring probe. Based on the measurements, translational displacements in anteroposterior (z), mediolateral (x), and craniocaudal (y) directions were calculated. Based on the displacements in x, y and z directions, systematic and random error were calculated and three-dimensional radial displacement vector was determined. Systematic and random errors were used to derive CTV to PTV margin. The errors were within ± 2 mm in 99.2% cases in anteroposterior direction (AP), in 99.6% cases in mediolateral direction (ML), and in 97.6% cases in craniocaudal direction (CC). In AP, ML and CC directions, systematic errors were 0.56, 0.38, 0.42 mm and random errors were 1.86, 1.36 and 0.73 mm, respectively. Mean radial displacement was 1.03 mm ± 0.34. CTV to PTV margins calculated by ICRU formula were 1.86, 1.45 and 0.93 mm; by Stroom's formula they were 2.42, 1.74 and 1.35 mm; by van Herk's formula they were 2.7, 1.93 and 1.56 mm (AP, ML and CC directions). Depth helmet with measuring probe provides a clinically viable way for assessing the relocation accuracy of GTC frame. The errors were within ± 2 mm in all directions. Systematic and random errors were more along the anteroposterior axes. According to the ICRU formula, a margin of 2 mm around the tumor seems to be adequate.
Collapse
Affiliation(s)
- Saikat Das
- Department of Radiation OncologyChristian Medical College VelloreIndia
| | - Rajesh Isiah
- Department of Radiation OncologyChristian Medical College VelloreIndia
| | - B. Rajesh
- Department of Radiation OncologyChristian Medical College VelloreIndia
| | - B. Paul Ravindran
- Department of Radiation OncologyChristian Medical College VelloreIndia
| | - Rabi Raja Singh
- Department of Radiation OncologyChristian Medical College VelloreIndia
| | | | - J. Subhashini
- Department of Radiation OncologyChristian Medical College VelloreIndia
| |
Collapse
|
9
|
The accuracy of frameless stereotactic intracranial radiosurgery. Radiother Oncol 2010; 97:390-4. [PMID: 21047692 DOI: 10.1016/j.radonc.2010.06.012] [Citation(s) in RCA: 52] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2010] [Revised: 05/31/2010] [Accepted: 06/07/2010] [Indexed: 11/23/2022]
Abstract
PURPOSE To determine the accuracy of frameless stereotactic radiosurgery using the BrainLAB ExacTrac system and robotic couch by measuring the individual contributions such as the accuracy of the imaging and couch correction system, the linkage between this system and the linac isocenter and the possible intrafraction motion of the patient in the frameless mask. MATERIALS AND METHODS An Alderson head phantom with hidden marker was randomly positioned 31 times. Automated 6D couch shifts were performed according to ExacTrac and the deviation with respect to the linac isocenter was measured using the hidden marker. ExacTrac-based set-up was performed for 46 patients undergoing hypofractionated stereotactic radiotherapy for 135 fractions, followed by verification X-rays. Forty-three of these patients received post-treatment X-ray verification for 79 fractions to determine the intrafraction motion. RESULTS The hidden target test revealed a systematic error of 1.5 mm in one direction, which was corrected after replacement of the system calibration phantom. The accuracy of the ExacTrac positioning is approximately 0.3 mm in each direction, 1 standard deviation. The intrafraction motion was 0.35±0.21 mm, maximum 1.15 mm. CONCLUSION Intrafraction motion in the BrainLAB frameless mask is very small. Users are strongly advised to perform an independent verification of the ExacTrac isocenter in order to avoid systematic deviations.
Collapse
|
10
|
Beltran C, Naik M, Merchant TE. Dosimetric effect of setup motion and target volume margin reduction in pediatric ependymoma. Radiother Oncol 2010; 96:216-22. [PMID: 20347495 DOI: 10.1016/j.radonc.2010.02.031] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2009] [Revised: 02/17/2010] [Accepted: 02/20/2010] [Indexed: 10/19/2022]
Abstract
PURPOSE Quantify the dosimetric effect of inter- and intrafractional motion on intensity-modulated radiation therapy (IMRT) and three-dimensional (3D) planning via changes in the generalized equivalent uniform dose (gEUD), predicted tumor control probability (TCP) and normal tissue complication probability (NTCP) for pediatric ependymoma. METHODS AND MATERIALS Twenty patients treated between 1998 and 2002 with a 3D plan (CTV = 1 cm, PTV = 5 mm) were selected. Two IMRT plans were created for the 1 cm CTV (PTV = 5 mm and PTV = 0 mm), and a third IMRT plan for a 5 mm CTV (PTV = 0 mm). Direct simulation with inter- and intrafractional motion was performed for 3D and IMRT plans based on daily pre and post-treatment cone beam CT information obtained from 20 well-matched patients (age, supine/prone, use of GA) on a localization protocol. Calculated TCP, NTCP, Conformity Index (CI), and predictive IQ were compared. RESULTS IMRT improved the calculated TCP by 2.8+/-2.8 vs. 3D (p<0.001). Inter- and intrafractional motion results in a TCP loss of 0.4+/-0.7 (p=0.02) and 0.0+/-0.1 (p=0.14) for the IMRT plan with PTV = 0 mm. Mean NTCP for 3D and IMRT with PTV = 5 mm, PTV = 0 mm, and CTV = 5 mm for the cochlea was: 66.6, 29.4, 8.7. Mean NTCP change due to motion was <5%. CI was 0.70+/-0.06 for IMRT and 0.5+/-0.10 for 3D. Predictive IQ was 10.0+/-10.3 points higher for IMRT vs. 3D. CONCLUSIONS IMRT improves calculated TCP vs. 3D. Daily localization can allow for a safe reduction in the PTV margin, while maintaining target coverage; reducing the CTV margin can further reduce NTCP and may reduce future side-effects.
Collapse
Affiliation(s)
- Chris Beltran
- Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN 38120, USA.
| | | | | |
Collapse
|
11
|
Estall VJ, Eaton D, Burton KE, Jefferies SJ, Jena R, Burnet NG. Intensity-modulated radiotherapy plan optimisation for skull base lesions: practical class solutions for dose escalation. Clin Oncol (R Coll Radiol) 2010; 22:313-20. [PMID: 20181465 DOI: 10.1016/j.clon.2010.02.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2009] [Revised: 12/19/2009] [Accepted: 02/03/2010] [Indexed: 11/29/2022]
Abstract
AIMS To identify practical intensity-modulated radiotherapy planning solutions when attempting dose escalation in the skull base. MATERIALS AND METHODS Twenty cases of skull base meningioma were re-planned using a variation of beam number (three, five, seven and nine), beam arrangement (coplanar vs non-coplanar) and multileaf collimator (MLC) width (2.5 mm vs 10 mm) to 60 Gy/30 fractions. Plan quality and planning target volume coverage was assessed using planning target volume V(95%), equivalent uniform dose (EUD) and integral dose. RESULTS Critical structures were maintained below clinical tolerance levels. The 2.5 mm MLC achieved an average improvement in V(95%) by 22.8% (P=0.0003), EUD by 3.7 Gy (P=0.002) and reduced the integral dose by 13.4 Gy (P=0.0001). V(95%) and the integral dose improved with five vs three beams and seven vs five beams, but did not change with nine vs seven beams. There was no effect of beam number on EUD. There was no difference in V(95%) (P=0.54), integral dose (P=0.44) or EUD (P=0.47) for beam arrangement used. Segments per plan increased by a factor of 1.5 with each addition of two beams to a plan, and by a factor of 2.5 for 2.5 mm MLC plans vs 10 mm MLC plans. CONCLUSIONS We present evidence-based planning solutions for skull base intensity-modulated radiotherapy, and show that 2.5 mm MLC and five to seven beams can achieve safe dose escalation up to 60 Gy. This must be balanced with an increase in segmentation, which will increase treatment times.
Collapse
Affiliation(s)
- V J Estall
- PeterMac Cancer Centre, East Melbourne, VIC, Australia.
| | | | | | | | | | | |
Collapse
|
12
|
Beltran C, Trussell J, Merchant TE. Dosimetric impact of intrafractional patient motion in pediatric brain tumor patients. Med Dosim 2009; 35:43-8. [PMID: 19931014 PMCID: PMC3800030 DOI: 10.1016/j.meddos.2009.01.004] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2008] [Revised: 01/09/2009] [Accepted: 01/12/2009] [Indexed: 12/25/2022]
Abstract
The purpose of this study was to determine the dosimetric consequences of intrafractional patient motion on the clinical target volume (CTV), spinal cord, and optic nerves for non-sedated pediatric brain tumor patients. The patients were immobilized for treatment using a customized thermoplastic full-face mask and bite-block attached to an array of reflectors. The array was optically tracked by infra-red cameras at a frequency of 10 Hz. Patients were localized based on skin/mask marks and weekly films were taken to ensure proper setup. Before each noncoplanar field was delivered, the deviation from baseline of the array was recorded. The systematic error (SE) and random error (RE) were calculated. Direct simulation of the intrafractional motion was used to quantify the dosimetric changes to the targets and critical structures. Nine patients utilizing the optical tracking system were evaluated. The patient cohort had a mean of 31 +/- 1.5 treatment fractions; motion data were acquired for a mean of 26 +/- 6.2 fractions. The mean age was 15.6 +/- 4.1 years. The SE and RE were 0.4 and 1.1 mm in the posterior-anterior, 0.5 and 1.0 mm in left-right, and 0.6 and 1.3 mm in superior-inferior directions, respectively. The dosimetric effects of the motion on the CTV were negligible; however, the dose to the critical structures was increased. Patient motion during treatment does affect the dose to critical structures, therefore, planning risk volumes are needed to properly assess the dose to normal tissues. Because the motion did not affect the dose to the CTV, the 3-mm PTV margin used is sufficient to account for intrafractional motion, given the patient is properly localized at the start of treatment.
Collapse
Affiliation(s)
- Chris Beltran
- Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
| | | | | |
Collapse
|
13
|
Abstract
The multimodality management of visual pathway tumors frequently involves radiation. Most commonly, photons are delivered via multiple focused beams aimed at the tumor while sparing adjacent tissues. The dose can be delivered in multiple treatments (radiation therapy) or in a single treatment (radiosurgery). Children with visual pathway gliomas should be treated with chemotherapy alone, delaying the use of radiation therapy until progression. Definitive radiation therapy of optic nerve sheath meningiomas results in stable vision in most patients. Radiation therapy or radiosurgery for pituitary tumors can result in control of both tumor growth and hormone hypersecretion. Postoperative radiation therapy or radiosurgery of craniopharyngiomas significantly improves local control rates compared with surgery alone. Radiation therapy is highly effective for eradicating orbital pseudolymphoma and lymphoma. The risk of complications from radiation treatment is dependent on the organ at risk, the cumulative dose it receives, and the dose delivered per fraction.
Collapse
|
14
|
Foweraker KL, Burton KE, Maynard SE, Jena R, Jefferies SJ, Laing RJC, Burnet NG. High-dose Radiotherapy in the Management of Chordoma and Chondrosarcoma of the Skull Base and Cervical Spine: Part 1 — Clinical Outcomes. Clin Oncol (R Coll Radiol) 2007; 19:509-16. [PMID: 17524633 DOI: 10.1016/j.clon.2007.04.004] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2007] [Revised: 03/09/2007] [Accepted: 04/13/2007] [Indexed: 11/19/2022]
Abstract
AIMS Patients with chordoma and chondrosarcoma in the skull base present a complex multidisciplinary problem. These tumours are rare and occur in difficult anatomical regions. We reviewed the local control and survival of patients treated in our centre. MATERIALS AND METHODS Between 1996 and 2005, 12 adult cases of chordoma (nine) and chondrosarcoma (three) in the skull base or cervical spine were treated in our centre. The median follow-up is currently 38 months. One patient was treated with palliative intent. In 10 cases the prescription dose was 65 Gy in 39 fractions. The target volumes were measured, and the target maximum and minimum doses and the equivalent uniform dose (EUD) for the phase I plans were recorded. RESULTS Local control was achieved in 11 of 12 cases. One chordoma patient failed locally, and one other died of metastatic disease despite local control. The 3- and 5-year cause-specific survival for the series was 88 and 75%, respectively. The mean phase I planning target volume (PTV) was 120.4 cm(3). The median minimum dose in the phase I PTV was 81.0%. The median EUD (expressed as a percentage of the prescribed dose) for the phase I PTV, calculated using a value for the exponent a of -15, was 98.3%. The phase I EUD was below 80% in two of the 12 cases. CONCLUSIONS Our results confirm a need for aggressive local surgery and high-dose radiotherapy, and endorse multidisciplinary working. Although charged particle therapy is accepted as providing optimal treatment plans, in eight of our patients travel abroad would not have been feasible. This series provides encouraging results for carefully planned photon conformal radiotherapy, carried out in close collaboration with a specialist surgical team.
Collapse
Affiliation(s)
- K L Foweraker
- Neuro-oncology Unit, Oncology Centre, Addenbrooke's Hospital, Cambridge, UK
| | | | | | | | | | | | | |
Collapse
|
15
|
Horan G, Whitfield GA, Burton KE, Burnet NG, Jefferies SJ. Fractionated Conformal Radiotherapy in Vestibular Schwannoma: Early Results from a Single Centre. Clin Oncol (R Coll Radiol) 2007; 19:517-22. [PMID: 17400433 DOI: 10.1016/j.clon.2007.02.017] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2006] [Revised: 01/21/2007] [Accepted: 02/28/2007] [Indexed: 10/23/2022]
Abstract
AIMS To assess the local control and cranial nerve toxicity in vestibular schwannoma patients treated with fractionated conformal radiotherapy delivered using a linear accelerator. MATERIALS AND METHODS Ninety-five patients were referred for consultation to the Oncology Department in Addenbrookes Hospital between 1996 and 2005. The 42 cases who received fractionated conformal radiotherapy are the subject of this analysis. All patients had radiological or symptomatic progression. Conformal radiotherapy was prescribed at 50Gy in 30 fractions over 6 weeks, delivered using a linear accelerator. Patients were immobilised using either a beam direction shell or a Gill Thomas Cosman relocatable stereotactic head frame. RESULTS The median age was 63 years (range 28-81) with 57% men. The average tumour size was 21.5mm on magnetic resonance imaging. Before treatment, 20 (48%) patients were deemed to have useful hearing on the affected side. The median follow-up was 18.6 months (range 0.3-6.5 years) and the actuarial local control rate at 2.5 years was 96.9% (one patient progressed after treatment). In previously hearing patients, the actuarial rate of useful hearing preservation was 100%, and the rate of mild hearing loss was 20% at 1 year and 26.7% at 2.5 years of follow-up. There were five neurofibromatosis type 2 patients treated, two of whom had useful hearing before radiotherapy. In one patient this was affected, with a 20dB loss, although he still has useful hearing. In those with normal facial nerve function before radiotherapy (n=40), this was preserved in 96.8% at 2.5 years. Trigeminal nerve function was preserved in all patients (n=38) who had normal nerve function before radiotherapy. CONCLUSION Although follow-up was relatively short in this single institution series, fractionated linear accelerator radiotherapy gave excellent local control, useful hearing preservation and retained cranial nerve function in vestibular schwannoma.
Collapse
Affiliation(s)
- G Horan
- Oncology Centre, Addenbrookes Hospital, Cambridge, UK.
| | | | | | | | | |
Collapse
|
16
|
Higgins PD, Gerbi BJ, Macedon M, Dusenbery KE. Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma. J Appl Clin Med Phys 2006; 7:9-17. [PMID: 17533322 PMCID: PMC5722448 DOI: 10.1120/jacmp.v7i2.2161] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2005] [Revised: 01/26/2006] [Accepted: 12/31/1969] [Indexed: 12/04/2022] Open
Abstract
In this report, we discuss the application of a modified Gill‐Thomas‐Cosman (GTC) relocatable head frame to enable fractionated stereotactic radiotherapy (SRT) of infants under anesthesia. This system has been used to treat two infants, ages 12 and 18 months, for bilateral retinoblastoma on a Varian 6/100 linear accelerator. The GTC head frame was used to reproducibly position and treat the orbits of these children to between 2520 cGy and 3960 cGy in 180‐cGy fractions. A standard head and neck tray, with accompanying thermoplastic mask, was adapted to mount to the head frame to enable these treatments. We found the maximum average deviation in the repeat fixations, as compared with the initial fitting data, to be ±2mm. The overall average difference and standard deviation in measurement was 0.47±0.63mm for the first case and 0.19±0.94mm for the second case, with a combined average of 0.35±0.79mm overall from a total of 381 point measurements. The stereotactic treatment plan (Radionics®) incorporated a single isocenter for each orbit and 3 or 4 arcs per isocenter. An intercomparison has been made between this technique and a standard lateral field technique, designed using the stereotactic radiosurgery (SRS) planning system. Dose‐volume histograms and corresponding normal tissue complication probabilities (NTCP) based on pediatric bone growth inhibition have been calculated for each method for the orbital bone areas. We found that the NTCP is reduced from 95% or more in the standard treatment method to 16% or less with SRT. Use of the modified head frame provides excellent setup reproducibility, facilitates access to patients for anesthesia, and reduces the chances of a poor cosmetic result in these growing children. PACS number: 87.53.Ly
Collapse
Affiliation(s)
- Patrick D Higgins
- Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota, Minneapolis, Minnesota 55455, USA.
| | | | | | | |
Collapse
|
17
|
Engelsman M, Rosenthal SJ, Michaud SL, Adams JA, Schneider RJ, Bradley SG, Flanz JB, Kooy HM. Intra- and interfractional patient motion for a variety of immobilization devices. Med Phys 2006; 32:3468-74. [PMID: 16372417 DOI: 10.1118/1.2089507] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The magnitude of inter- and intrafractional patient motion has been assessed for a broad set of immobilization devices. Data was analyzed for the three ordinal directions--left-right (x), sup-inf (y), and ant-post (z)--and the combined spatial displacement. We have defined "rigid" and "non-rigid" immobilization devices depending on whether they could be rigidly and reproducibly connected to the treatment couch or not. The mean spatial displacement for intrafractional motion for rigid devices is 1.3 mm compared to 1.9 mm for nonrigid devices. The modified Gill-Thomas-Cosman frame performed best at controlling intrafractional patient motion, with a 95% probability of observing a three-dimensional (3D) vector length of motion (v95) of less than 1.8 mm, but could not be evaluated for interfractional motion. All other rigid and nonrigid immobilization devices had a v95 of more than 3 mm for intrafractional patient motion. Interfractional patient motion was only evaluated for the rigid devices. The mean total interfractional displacement was at least 3.0 mm for these devices while v95 was at least 6.0 mm.
Collapse
Affiliation(s)
- Martijn Engelsman
- Northeast Proton Therapy Center, Massachusetts General Hospital and Department of Radiation Oncology, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, USA
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Miyabe Y, Yano S, Okada T, Nakata M, Teshima T, Nagata Y, Hiraoka M. [Evaluation of positioning reproducibility using a re-locatable head frame for stereotactic radiotherapy]. Nihon Hoshasen Gijutsu Gakkai Zasshi 2004; 60:1444-51. [PMID: 15565014 DOI: 10.6009/jjrt.kj00003326547] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
In fractionated stereotactic radiotherapy (SRT), the accuracy of patient relocation is very important. The Gill-Thomas-Cosman (GTC) re-locatable stereotactic frame is used for patient immobilization. A depth helmet and measuring probe are used to check the stability of the patient's head position relative to the GTC frame. However, displacement error caused by rotation of the patient's head is not considered in the depth-helmet measurement. Consequently, displacement of the isocenter position cannot be confirmed by the measurement obtained from the depth helmet. In this study, we evaluated the precision of reproducibility by comparing measurement values of the depth helmet with the displacement of anatomical position on a CT image. We analyzed 21 setups of 8 patients immobilized for SRT using the GTC frame, between June 2001 and June 2003. The reproducibility of the GTC frame was checked at each treatment by comparing it with the treatment planning position. The average discrepancy of the GTC frame set-up measured by the depth helmet was 0.6 mm, with a standard deviation of 0.3 mm. The result measured by CT was 0.7 mm, with a standard deviation of 0.4 mm. When the error of each measurement point was within 1.0 mm, the accuracy of relocation of the patient could be considered clinically acceptable. Displacement error not considered in the measurement of the depth helmet could be evaluated by using CT.
Collapse
Affiliation(s)
- Yuki Miyabe
- Department of Medical Physics & Engineering, Osaka University Graduate School of Medicine
| | | | | | | | | | | | | |
Collapse
|
19
|
McNair HA, Adams EJ, Clark CH, Miles EA, Nutting CM. Implementation of IMRT in the radiotherapy department. Br J Radiol 2003; 76:850-6. [PMID: 14711771 DOI: 10.1259/bjr/19737738] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
This paper describes the implementation of intensity modulated radiotherapy (IMRT) in a radiotherapy department. When preparing to set-up an IMRT programme, it is important to review departmental protocols with regard to immobilization, CT planning, treatment planning and verification. Any additional quality assurance steps also need to be fully understood. A new IMRT programme is most likely to be successful if it builds on established clinical experience with three-dimensional conformal radiotherapy (CRT). Training of radiographers, clinicians and physicists is critical, and both team-work and communication are vital to ensure a smooth transition from 3DCRT to IMRT delivery in the clinic.
Collapse
Affiliation(s)
- H A McNair
- Department of Radiotherapy, Royal Marsden NHS Trust and Institute of Cancer Research, Downs Road, Sutton, Surrey, UK
| | | | | | | | | |
Collapse
|
20
|
Stieber VW, Bourland JD, Tome WA, Mehta MP. Gentlemen (and ladies), choose your weapons: Gamma knife vs. linear accelerator radiosurgery. Technol Cancer Res Treat 2003; 2:79-86. [PMID: 12680787 DOI: 10.1177/153303460300200202] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
This article compares and contrasts Gamma Knife radiosurgery with linear accelerator-based radiosurgery; where appropriate, Cyberknife technology is discussed. Topics covered are: positioning of the head (invasive versus non-invasive positioning systems); collimator construction; beam properties; beam arrangements; treatment planning; and issues regarding manpower (including a discussion of patient repositioning during treatment), machine availability, and financial considerations.
Collapse
Affiliation(s)
- Volker W Stieber
- Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1030, USA.
| | | | | | | |
Collapse
|
21
|
Tome WA, Mehta MP, Meeks SL, Buatti JM. Fractionated stereotactic radiotherapy: a short review. Technol Cancer Res Treat 2002; 1:153-72. [PMID: 12622509 DOI: 10.1177/153303460200100301] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Currently, optimally precise delivery of intracranial radiotherapy is possible with stereotactic radiosurgery and fractionated stereotactic radiotherapy. We present in this article a review of the underlying basic physical and radiobiological principles of fractionated stereotactic radiotherapy and review the clinical experience for ateriovenus malformations, pituitary adenomas, mengiomas, vestibular schwanomas, low grade astrocytomas, malignant gliomas, and brain metastases.
Collapse
Affiliation(s)
- Wolfgang A Tome
- Department of Human Oncology, Medical School, University of Wisconsin, 600 Highland Ave., Madison, WI 53792, USA.
| | | | | | | |
Collapse
|